インドの医薬品市場:ジェネリック医薬品、OTC医薬品、特許薬、バイオシミラー...市場調査レポートについてご紹介

【英文タイトル】Indian Pharmaceutical Market Forecast 2016-2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 The Indian Pharmaceutical Market Overview
1.2 Indian Pharmaceutical Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain

2. Indian Healthcare: Overview
2.1 India: Demographic Indicators Overview
2.2 Indian Healthcare system: Overview
2.2.1 Rashtriya Swasthya Bima Yojana – Bringing Healthcare Coverage to India’s Poorest Workers
2.3 Analysis of India’s Healthcare Expenditure
2.4 State Bodies regulating the Indian Pharmaceutical Market
2.4.1 The Drugs and Cosmetics Act, 1940

3. Indian Pharmaceutical Market: Discussions and Predictions 2016-2026
3.1 Indian Pharmaceutical Market: The Third Biggest Market in the World by Volume, 2015
3.2 Indian Pharmaceutical Market: Overall Revenue Forecast 2016-2026

4. Medical Treatment Needs in India, 2016-2026
4.1 Disease Prevalence in India, 2016-2026
4.2 Disease Incidence in India, 2016-2026
4.3 Disease Mortality Rates in India, 2016-2026
4.3.1 Top Causes of Death in India
4.3.2 Top Causes of Death in India: Mortality Projections, 2016-2026

5. Indian Pharmaceutical Market: Leading Therapeutic Areas, 2016-2026
5.1 Leading Therapeutic Areas in the Indian Pharmaceutical Market: Overview, 2015
5.2 Indian Pharmaceutical Market: Leading Therapeutic Areas Forecasts, 2016-2026
5.3 Infectious Disease Therapeutics: Overview, 2015
5.3.1 Infectious Disease Drugs Market: Forecast, 2016-2026
5.3.2 Diarrheal Diseases Responsible for Over Half a Million Annual Deaths, 2015
5.3.3 Lower Respiratory Tract Infections Among Leading Causes of Death in 2015
5.3.4 Tuberculosis Still Rife in India
5.3.5 Malaria, Risk and Opportunity
5.3.6 HIV in India: Growing Therapeutic Area Worth Watching
5.3.7 Drivers and Restraints for the Infectious Diseases Pharmaceutical Segment, 2015-2026
5.4 Cardiovascular Therapeutic Segment: Overview, 2015
5.4.1 Cardiovascular Disease – India’s Leading Cause of Death, 2015
5.4.2 Cardiovascular Drugs Market: Forecast, 2016-2026
5.4.3 Drivers and Restraints for the Indian Cardiovascular Drugs Market, 2015-2026
5.5 Gastro-Intestinal Therapeutic Segment: Overview, 2015
5.5.1 Gastro-Intestinal Drugs Market: Forecast, 2016-2026
5.5.2 Gastro-Intestinal Drugs in India: Challenges and Opportunities
5.5.3 Drivers and Restraints for the Gastro-Intestinal Drugs Segment, 2015
5.6 Respiratory Therapeutic Segment: Overview, 2015
5.6.1 Respiratory Disease Drugs Market: Forecast, 2016-2026
5.6.2 Drivers and Restraints for the Respiratory Diseases Segment, 2015
5.7 Pain Relief / Analgesics Therapeutic Segment: Overview, 2015
5.7.1 Pain Relief / Analgesics Drugs Market: Forecast, 2016-2026
5.7.2Drivers and Restraints for the Pain Relief / Analgesics Drugs Segment, 2015
5.8 Diabetes Therapeutic Segment: Overview, 2015
5.8.1 Diabetes Drugs Market: Forecast, 2016-2026
5.8.2 Drivers and Restraints for the Diabetes Drugs Segment, 2015
5.9 Vitamins / Minerals / Nutrients Therapeutic Segment: Overview, 2015
5.9.1 Vitamins / Minerals / Nutrients Drugs Market: Forecast, 2016-2026
5.9.2 Vitamins / Minerals / Nutrients in India: Challenges and Opportunities
5.9.3 Drivers and Restraints for the Vitamins / Minerals / Nutrients Drugs Segment, 2015
5.10 Dermatological Therapeutic Segment: Overview, 2015
5.10.1 Dermatological Drugs Market: Forecast, 2016-2026
5.10.2 Drivers and Restraints for the Dermatological Drugs Segment, 2015
5.11 Central Nervous System (CNS) Therapeutics: Overview, 2015
5.11.1 CNS Drugs Market: Forecast, 2016-2026
5.11.2 Intentional Injury Among the Top 10 Leading Causes of Death, 2015:
5.11.3 India’s Aging Population: Driver for the CNS Segment
5.11.4 Drivers and Restraints for the CNS Drugs Segment, 2015
5.12 Gynaecological Treatment Market Overview: 2015
5.12.1 Infant Mortality Still High in India
5.12.2 Indian Gynaecological Treatments Market: Forecast, 2016-2026
5.12.3 Drivers and Restraints for the Gynaecological Segment, 2015
5.13 Other Pharmaceutical Products Market Overview: 2015
5.13.1 Incidence of Cancer in India is Rising
5.13.2 Indian Other Treatments Market: Forecast, 2016-2026

6. Indian Pharmaceutical Market: Leading Drug Types, 2016-2026
6.1 Drug Types in the Indian Market: Overview, 2015
6.2 Growth Forecasts for Leading Drug Types in India, 2016-2026
6.3 Generic Drugs Dominate the Indian Pharmaceutical Market
6.3.1 Indian Generics: Overview, 2015
6.3.2 Indian Generic Drugs Market: Forecast, 2016-2026
6.3.3 Branded Generics Preferred by Many Indian Patients
6.3.4 Drivers and Restraints for the Generic Drug Market in India, 2015
6.4 Indian Over-The-Counter (OTC) Drugs Market: Overview, 2015
6.4.1 Indian OTC Market: Forecast, 2016-2026
6.4.2 Drivers and Restraints of the Indian OTC Market
6.5 Indian Patented Drugs Market: Overview, 2015
6.5.1 Indian Patented Drugs Market: Forecasts, 2016-2026
6.5.2 Drivers and Restraints for the Indian Patented Drugs Market
6.6 Indian Biosimilar Drugs, 2015
6.6.1 Indian Biosimilar Drugs Market: Forecast, 2016-2026
6.6.2 A Number of Blockbuster Drugs Coming Off-Patent Over the Next Decade
6.6.3 Drivers and Restraints of the Indian Biosimilar Drugs Market

7. The Leading Companies in the Indian Pharmaceutical Market, 2016-2026
7.1 Indian Pharmaceutical Market Overview
7.1.1 Indian Pharmaceutical Patent Law and the Effect on Big Pharmaceutical Companies
7.2 Top 50 Domestic Indian Pharmaceutical Companies, 2015
7.3 Sun Pharmaceuticals Industries Limited
7.3.1 Sun Pharma: Global Presence
7.3.1.1 Sun Pharmaceutical Sales by Region, 2015
7.3.2 Sun Pharmaceuticals Business Performance 2006-2015
7.3.3 Sun Pharmaceutical: Ranbaxy Laboratories Acquisition is the Largest Ever Deal Made by an Indian Pharmaceutical Company
7.3.3.1 Other Major M&A Activity
7.4 Abbott Healthcare Private Limited (Abbott India)
7.4.1 Abbott India: Business Performance 2006-2015
7.4.2 Abbott India: Key Brands in the Indian Pharmaceutical Market
7.4.3 Abbott India: Major and Recent M&A Activity
7.5 Cipla Ltd.
7.5.1 Cipla: Business Performance 2006-2015
7.6 Cadila Healthcare Limited
7.6.1 Cadila: Business Performance 2006-2015
7.6.2 Cadila Healthcare Revenue by Therapeutic Area 2015
7.6.3 Cadila Healthcare Revenue by Business Area 2015
7.7 GlaxoSmithKline Pharmaceuticals Limited
7.7.1 GlaxoSmithKline India: Business Performance 2006-2015
7.7.2 GlaxoSmithKline India: Revenue by Product Type, 2015
7.8 Pfizer Limited. India
7.8.1 Pfizer India: Business Performance 2006-2015
7.7.2 Pfizer India: Revenue by Product Type, 2015
7.9 Lupin
7.9.1 Lupin: Business Performance 2006-2015
7.9.2 Lupin Revenue by Therapeutic Area, 2015

8. Qualitative Analysis of the Indian Pharmaceutical Market, 2015
8.1 Indian Pharmaceutical Market: Drivers and Restraints
8.2 SWOT Analysis of the Indian Pharmaceutical Market, 2015-2026
8.3 Strengths
8.3.1 Increasing Investment in the Healthcare System
8.3.2 The Disease Burden and GDP Both Growing
8.3.3 India’s Population Set to Become the World’s Largest by 2030
8.3.4 India Popular for Pharmaceutical Outsourcing
8.4 Weaknesses
8.4.1 Stringent Pricing Regulations Hit the Indian Pharmaceutical Market
8.4.2 Poor Infrastructure Threatens to Hinder Market Potential
8.4.3 Intense Competition Driving Down Drug Prices
8.5 Opportunities
8.5.1 Global Demand for Generics Rising
8.5.2 National Rural Health Mission Driving Healthcare Access in Rural Areas
8.5.3 Significant Investment from MNCs Expected
8.5.4 Innovative Biotechnology Sector Set to Capitalise on Patent Expiries
8.6 Threats
8.6.1 Rise of Other Low-Cost Generic Exporters
8.6.2 Will the Indian Government Stick to Increasing Healthcare Expenditure?
8.6.3 Recent Warnings and Export Bans from Regulatory Bodies Hit Confidence in Indian Pharmaceuticals
8.7 Porter’s Five Forces Analysis of the Indian Pharmaceutical Market
8.7.1 Rivalry Among Competitors [High]
8.7.2 Threat of New Entrants [Low]
8.7.3 Power of Suppliers [Medium]
8.7.4 Power of Buyers [High]
8.7.5 Threat of Substitutes [Low]

9. Conclusion
9.1 The Indian Pharmaceutical Market: Growing Global Market Share
9.2 Indian Pharmaceutical Market: Chronic Diseases Becoming Increasingly Prevalent
9.3 Commercial Drivers of the Indian Pharmaceutical Market
9.4 Commercial Restraints of the Indian Pharmaceutical Market
9.5 Concluding Remarks

10. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form


【レポート販売概要】

■ タイトル:インドの医薬品市場:ジェネリック医薬品、OTC医薬品、特許薬、バイオシミラー
■ 英文:Indian Pharmaceutical Market Forecast 2016-2026
■ 発行日:2015年12月
■ 調査会社:visiongain
■ 商品コード:VGAIN5122116
■ 調査対象地域:インド
  • 世界のVoLTE市場:機会、課題、戦略、予測
    VoLTE (Voice over LTE) technology allows a voice call to be placed over an LTE network, enabling operators to reduce reliance on legacy circuit-switched networks. Powered by IMS (IP Multimedia Subsystem) architecture, VoLTE brings a host of benefits to mobile operators ranging from the ability to refarm legacy 2G and 3G spectrum to offering their subscribers a differentiated service experience thr …
  • 世界の小型自動車用電気モーター市場【2015年1月更新版】
    This latest just-auto report edition offers a global review of the OE automotive electric motors sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE electric motors market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their str …
  • ガスクロマトグラフィーの世界市場予測(~2022年):装置、付属品、消耗品
    The global gas chromatography market is expected to reach USD 3.67 billion by 2022 from USD 2.64 billion in 2016, at a CAGR of 6.2%. In this report, the gas chromatography market is segmented on the basis of instruments, consumables and accessories, end users, and regions. The instruments market is segmented into systems, detectors, autosamplers, and fraction collectors. The systems segment is exp …
  • 医療用ロボットの世界市場2019-2023
    120 pages, November 2018 About this market The medical robots industry have witnessed several technological developments in the last few years. Medical robot vendors are focusing on the development of rehabilitation robots that improve the mobility in patients who have lost mobility in their limbs. Technological advancements have allowed medical robots to dispense medicines and provide homecare wh …
  • Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Infectious Immunology market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within five m …
  • 膀胱癌:市場分析及び予測(~2017)
    OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2017 Summary Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. Although it is the ninth most common cancer worldwide in men and women, with the highest recurrence rate of any malignancy, relatively little is known about its etiology. There has been little development over th …
  • 角膜厚測定の世界市場2019-2023
    Global Corneal Pachymetry Market: About this market Technavio’s corneal pachymetry market analysis considers sales from both non-handheld and hand-held. Our analysis also considers the sales of corneal pachymetry in Asia, Europe, North America, and ROW. In 2018, the non-handheld segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as …
  • インビトロ毒物検査の世界市場予測(~2022年)
    “The global in vitro toxicology testing market is projected to grow at a CAGR of 6.6%.”The in vitro toxicology testing market is expected to reach USD 8.74 billion by 2022 from an estimated USD 6.34 billion in 2017, at a CAGR of 6.6%. The key factors driving the growth of this market include opposition to animal testing, growing demand for in vitro technology in the European market, new and promis …
  • 緑内障治療薬の世界市場予測および分析
    PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2023 Summary Glaucoma is a leading cause of preventable blindness globally. This chronic progressive optic neuropathy causes irreversible vision loss through damage to the optic nerve. There are currently no treatments that can directly prevent this damage, and all commercially available glaucoma therapies focus on lowering elevat …
  • 世界の薬剤管理システム市場動向(2012-2016)
    TechNavio’s analysts forecast the Global Medication Management System market to grow at a CAGR of 5.42 percent over the period 2012-2016. One of the key factors contributing to this market growth is increase in aging population. The Global Medication Management System market has also been witnessing the trend of increase in mergers and acquisitions. However, reluctance of patients to adopt medicat …
  • 軍用及びセキュリティ用放射線検知装置の世界市場
    The security and military sectors are two of the fastest-growing areas for radiation detection, attracting heavy investments at the present time. One obvious factor is the supposed increase in terrorist activity, and a need for monitoring and control aided by radiation monitors deployed at strategic positions for a number of protective or preventative goals. These include confiscating illicit radi …
  • 多形性膠芽腫治療薬の世界市場2015-2019
    About Glioblastoma Multiforme Glioblastoma multiforme is the most aggressive variant of malignant brain cancer. It has a poor prognosis with low rate of survival, a median of one year. The primary brain tumor happens due to uncontrolled cell division and developments in the brain. The tumors can be found in the glial cells or the neuron. The one which develops in the glial cells (astrocytes and ol …
  • 2014年戦略提言:Aeromonads診断検査市場
    The report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Co …
  • 世界のCEA検査市場
    The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technologi …
  • 磁気共鳴画像法(MRI)システムの世界市場:インサイト、市場機会、市場シェア、市場予測
    The global magnetic resonance imaging (MRI) systems market is projected to grow at a CAGR of 5.8% during 2016-2022, and it is estimated to contribute around $7250 million till 2021. Magnetic resonance imaging is a technique that uses radio waves and magnetic field to create detailed images of tissues and organs of the human body. The images given by MRI is used for the diagnosis and treatment of t …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。